Akebia Ther Stock Target Price and Analyst Consensus
| AKBA Stock | USD 1.12 0.04 3.70% |
The current analyst and expert consensus on Akebia Ther is Strong Buy, with only one strong buy opinion. The current projected Akebia Ther target price consensus is 3.88 with 3 analyst opinions. The most common way Akebia Ther analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Akebia Ther executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Akebia Ther. We encourage you to use your own analysis of Akebia Ther to validate this buy or sell advice. Akebia Ther buy-or-sell recommendation module provides average expert sentiment on the projected Akebia Ther target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Akebia Ther to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.
Lowest Forecast 3.53 | Highest Forecast 4.31 | Target Price 3.88 |
Akebia |
It's important to approach Akebia Ther's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Akebia Ther price targets
Akebia Ther's stock target price is an estimate of its future price, usually made by analysts. Using Akebia Ther's target price to determine if it is a suitable investment can be done through the following steps:- Look at Akebia Ther's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Akebia Ther's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Akebia Ther Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Akebia Ther is a key component of Akebia Ther valuation and have some predictive power on the future returns of a Akebia Ther.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akebia Ther's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Hedge Favorites Invested over 70 shares | |
 | Driverless Cars Invested over 70 shares | |
 | Cash Cows Invested few shares | |
 | Artificial Intelligence Invested few shares | |
Check out Macroaxis Advice on Akebia Ther to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.Note that the Akebia Ther information on this page should be used as a complementary analysis to other Akebia Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Akebia Stock analysis
When running Akebia Ther's price analysis, check to measure Akebia Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Ther is operating at the current time. Most of Akebia Ther's value examination focuses on studying past and present price action to predict the probability of Akebia Ther's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Ther's price. Additionally, you may evaluate how the addition of Akebia Ther to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
The data published in Akebia Ther's official financial statements usually reflect Akebia Ther's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Akebia Ther. For example, before you start analyzing numbers published by Akebia accountants, it's critical to develop an understanding of what Akebia Ther's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Akebia Ther's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Akebia Ther's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Akebia Ther's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Akebia Ther. Please utilize our Beneish M Score to check the likelihood of Akebia Ther's management manipulating its earnings.